The aim of this study was to examine CRC regarding the expression of FAP as a potential candidate for targeted imaging and therapy and to correlate the results with other immunohistochemical parameters in the TME such as p53, β-catenin, Ki-67 and CD3. The gene discussed is TP53; the disease is colorectal carcinoma.